Market Research Logo

Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025

Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025

The global mammalian polyclonal IgG antibody market size is expected to reach USD 1.21 billion by 2025 expanding at a CAGR of 5.1%, according to a new report by Grand View Research, Inc. Advantages over other forms of antibodies, increasing global R&D investments, and rising adoption of novel diagnostic procedures are factors driving the market. Global rise in chronic and infectious diseases also play a key role in propelling the market growth.

Polyclonal antibodies are the most preferred choice in routine laboratory tests, such as ELISA, microarray assays, western blotting, flow cytometry, and immunohistochemistry. Production of these does not require skilled professionals and large batches can be produced as per client requirements. A polyclonal antibody can recognize multiple antigens on one epitope and therefore can be utilized in the study of various diseases ranging from cancer to metabolic diseases. Denatured proteins are often detected with the use of polyclonal antibodies.

Thus, increasing use of these products in the treatment of several chronic diseases is also anticipated to fuel growth in the near future. Rising investments by major pharma companies, such as Novartis and Roche, for the development of therapeutic antibodies and novel diagnostic techniques and for QC purposes are also driving the market growth. For instance, R&D investments by top 10 biotech companies increased from USD 8.2 billion in 2010 to USD 10.2 billion in 2016, accounting for a 13% increase.

Further key findings from the study suggest:

  • Large amount of polysera obtained from goats and predominant use of these animals as hosts has contributed to its large market share in 2017
  • Metabolic biomarkers are expected to hold the largest market share during the forecast period due to growing prevalence of chronic diseases, such as cardiovascular diseases (CVDs) and cancer
  • ELISA tests provide accurate diagnosis of disease, such as AIDS, Lyme disease, syphilis, pernicious anemia, Rocky Mountain spotted fever, squamous cell carcinoma, chickenpox, shingles, and other bacterial and viral infections, than other antibody-based assays contributing to its high market share
  • Availability of technologically advanced equipment and presence of major market players has attributed to the North American region garnering large market share
  • Asia Pacific is anticipated to gain significant market share in near future due to rising R&D investment and presence of target population
  • Few key companies in the global mammalian polyclonal IgG antibody market include Abcam PLC; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific; Merck KgaA; Cell Signaling Technologies, Inc.; and Hoffmann-La Roche Ltd.
Please note The report will be updated with the latest data and delivered to you within 3-4 business days.


Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Region-wise Market Calculation
1.4.1 Region-Wise Market: Base Estimates
1.4.2 Global Market: CAGR Calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
1.7 List of Primary Sources
1.7.1 Primary Interview Breakup
1.7.1.1 Data for Primary Interviews, by Sources
1.7.1.2 Data for Primary Interviews, by Region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Mammalian Polyclonal IgG Antibody Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Advantages Over Monoclonal Antibodies
3.1.1.2 Rising R & D investments
3.1.1.3 Increasing Adoption of Novel Diagnostic Procedures
3.1.2 Market Resraint Analysis
3.1.2.1 Stringent Regulatory Policies
3.1.3 Key Opportunities Prioritized
3.1.3.1 Key Opportunities Prioritized, by type
3.1.3.2 Key Opportunities Prioritized, by product
3.1.3.3 Key Opportunities Prioritized, by Application
3.1.3.4 Key Opportunities Prioritized, by End Use
3.1.4 Mammalian IgG Polyclonal Antibody - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.1.5 Industry Analysis - Porter's
3.1.6 Mammalian IgG Polyclonal Antibody Market: Company Market Position Analysis, 2017
Chapter 4 Mammalian Polyclonal IgG Antibody Market: Type Analysis
4.1 Type Business Analysis
4.2 Mammalian IgG Polyclonal Antibody Market: Type Movement Analysis
4.2.1 Goat
4.2.1.1 Goat Antibody Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.2.2 Rabbit
4.2.2.1 Rabbit Antibodies Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.2.3 Horse
4.2.3.1 Horse Antibodies Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.2.4 Mouse
4.2.4.1 Mouse Antibodies Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.2.5 Others
4.2.5.1 Other Antibodies Market Estimates and Forecasts, 2014 - 2025 (USD Million)
Chapter 5 Mammalian Polyclonal IgG Antibody Market: Product Analysis
5.1 Product Business Analysis
5.2 Cardiac Biomarkers
5.2.1 Cardiac Biomarkers Market Estimates and Forecasts, 2014 - 2025 (USD Million)
5.3 Metabolic Biomarkers
5.3.1 Metabolic Biomarkers Market Estimates and Forecasts, 2014 - 2025 (USD Million)
5.4 Renal Biomarkers
5.4.1 Renal Biomarkers Market Estimates and Forecasts, 2014 - 2025 (USD Million)
5.5 Others
5.5.1 Other Biomarkers Market Estimates and Forecasts, 2014 - 2025 (USD Million)
Chapter 6 Mammalian Polyclonal IgG Antibody Market: Application Analysis
6.1 Application Business Analysis
6.1.1 ELISA
6.1.1.1 ELISA Market Estimates and Forecasts, 2014 - 2025 (USD Million)
6.1.2 IMMUNOTURBIDIMETRY
6.1.2.1 Immunoturbidimetry Market Estimates and Forecasts, 2014 - 2025 (USD Million)
6.1.3 Immunoelectrophoresis
6.1.3.1 Immunoelectrophoresis Market Estimates and Forecasts, 2014 - 2025 (USD Million)
6.1.4 Antibody Identification
6.1.4.1 Antibody Identification Market Estimates and Forecasts, 2014 - 2025 (USD Million)
6.1.5 Immunohistochemistry
6.1.5.1 Immunohistochemistry Market Estimates and Forecasts, 2014 - 2025 (USD Million)
6.1.6 Immunocytochemistry
6.1.6.1 Immunocytochemistry Market Estimates and Forecasts, 2014 - 2025 (USD Million)
6.1.7 Western Blotting
6.1.7.1 Western Blotting Market Estimates and Forecasts, 2014 - 2025 (USD Million)
Chapter 7 Mammalian Polyclonal IgG Antibody Market: End Use Analysis
7.1 End Use Business Analysis
7.2 Hospitals
7.2.1 Hospitals Market Estimates and Forecasts, 2014 - 2025 (USD Million)
7.3 Diagnostic Centers
7.3.1 Diagnostic Centers Market Estimates and Forecasts, 2014 - 2025 (USD Million)
7.4 Academic and Research Centers
7.4.1 Academic and Research Institutes Market Estimates and Forecasts, 2014 - 2025 (USD Million)
Chapter 8 Mammalian Polyclonal IgG Antibody Market: Regional Estimates & Trend Analysis, by Type, Product, Application, End-Use
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.4 Latin America
8.4.1 Brazil
8.4.2 Mexico
8.5 MEA
8.5.1 South Africa
8.5.2 Saudi Arabia
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Abcam plc.
9.1.1.1 Company Overview
9.1.1.2 Strategic Initiatives
9.1.2 Bio-Rad Laboratories
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.3 Thermo Fisher Scientific
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.4 Merck KGaA
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.5 Cell Signaling Technologies
9.1.5.1 Company Overview
9.1.5.2 Product Benchmarking
9.1.6 Hoffmann-La Roche Ltd.
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
List of Tables
Table 1 North America mammalian polyclonal IgG antibody market, by country, 2014 - 2025 (USD Million)
Table 2 North America mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 3 North America mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 4 North America mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 5 North America mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 6 U.S. mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 7 U.S. mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 8 U.S. mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 9 U.S. mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million) 61
Table 10 Canada mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 11 Canada mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 12 Canada mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 13 Canada mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 14 Europe mammalian polyclonal IgG antibody market, by country, 2014 - 2025 (USD Million)
Table 15 Europe mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 16 Europe mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 17 Europe mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 18 Europe mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 19 U.K. mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 20 U.K. mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 21 U.K. mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 22 U.K. mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 23 Germany mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 24 Germany mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 25 Germany mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 26 Germany mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 27 France mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 28 France mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 29 France mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 30 France mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 31 Italy mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 32 Italy mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 33 Italy mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 34 Italy mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 35 Spain mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 36 Spain mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 37 Spain mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 38 Spain mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 39 Asia Pacific mammalian polyclonal IgG antibody market, by country, 2014 - 2025 (USD Million)
Table 40 Asia Pacific mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 41 Asia Pacific mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 42 Asia Pacific mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 43 Asia Pacific mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 44 Japan mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 45 Japan mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 46 Japan mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 47 Japan mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 48 China mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 49 China mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 50 China mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 51 China mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 52 India mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 53 India mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million) 84
Table 54 India mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 55 India mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 56 Latin America mammalian polyclonal IgG antibody market, by country, 2014 - 2025 (USD Million)
Table 57 Latin America mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 58 Latin America mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 59 Latin America mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 60 Latin America mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 61 Brazil mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 62 Brazil mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 63 Brazil mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 64 Brazil mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 65 Mexico mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 66 Mexico mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 67 Mexico mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 68 Mexico mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 69 MEA mammalian polyclonal IgG antibody market, by country, 2014 - 2025 (USD Million)
Table 70 MEA mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 71 MEA mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 72 MEA mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 73 MEA mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 74 South Africa mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 75 South Africa mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
Table 76 South Africa mammalian polyclonal IgG antibody market, by application, 2014 - 2025 (USD Million)
Table 77 South Africa mammalian polyclonal IgG antibody market, by end-use, 2014 - 2025 (USD Million)
Table 78 Saudi Arabia mammalian polyclonal IgG antibody market, by antibody type, 2014 - 2025 (USD Million)
Table 79 Saudi Arabia mammalian polyclonal IgG antibody market, by product, 2014 - 2025 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Primary interviews, by sources
Fig. 9 Primary interviews, by region
Fig. 10 Mammalian Polyclonal IgG antibody market summary
Fig. 11 Mammalian Polyclonal IgG antibody market trends and outlook
Fig. 12 Mammalian Polyclonal IgG antibody market segmentation
Fig. 13 Mammalian Polyclonal IgG antibody market driver impact
Fig. 14 Mammalian Polyclonal IgG antibody market restraint impact
Fig. 15 Key opportunities prioritized, type
Fig. 16 Key opportunities prioritized, product
Fig. 17 Key opportunities prioritized, application
Fig. 18 Key opportunities prioritized, end use
Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 20 Porter’s five forces analysis
Fig. 21 Mammalian Polyclonal IgG antibody type outlook: Key takeaways
Fig. 22 Mammalian Polyclonal IgG antibody market: Product movement analysis
Fig. 23 Global goat implants market, 2014 - 2025 (USD Million)
Fig. 24 Global rabbit antibodies market, 2014 - 2025 (USD Million)
Fig. 25 Global horse antibodies market, 2014 - 2025 (USD Million)
Fig. 26 Global mouse antibodies market, 2014 - 2025 (USD Million)
Fig. 27 Global other antibodies market, 2014 - 2025 (USD Million)
Fig. 28 Mammalian Polyclonal IgG antibody market shape outlook: Key takeaways
Fig. 29 Mammalian Polyclonal IgG antibody market: Shape movement analysis
Fig. 30 Global cardiac biomarkers market, 2014 - 2025 (USD Million)
Fig. 31 Global metabolic biomarkers market, 2014 - 2025 (USD Million)
Fig. 32 Global renal biomarkers market, 2014 - 2025 (USD Million)
Fig. 33 Global other biomarkers market, 2014 - 2025 (USD Million)
Fig. 34 Mammalian Polyclonal IgG antibody market application outlook: Key takeaways
Fig. 35 Mammalian Polyclonal IgG antibody market: Application movement analysis
Fig. 36 Global ELISA surgery market, 2014 - 2025 (USD Million)
Fig. 37 Global immunoturbidometry surgery market, 2014 - 2025 (USD Million)
Fig. 38 Global immunoelectrophoresis surgery market, 2014 - 2025 (USD Million)
Fig. 39 Global antibody identification surgery market, 2014 - 2025 (USD Million)
Fig. 40 Global immunohistochemistry market, 2014 - 2025 (USD Million)
Fig. 41 Global immunocytochemistry market, 2014 - 2025 (USD Million)
Fig. 42 Global western blotting market, 2014 - 2025 (USD Million)
Fig. 43 Mammalian Polyclonal IgG antibody market end use outlook: Key takeaways
Fig. 44 Mammalian Polyclonal IgG antibody market: End use movement analysis
Fig. 45 Global hospitals market, 2014 - 2025 (USD Million)
Fig. 46 Global diagnostic centers market, 2014 - 2025 (USD Million)
Fig. 47 Global academic and research institutes market, 2014 - 2025 (USD Million)
Fig. 48 Regional market place: Key takeaways
Fig. 49 Regional outlook, 2017 & 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report